Xianting Li

4.4k total citations · 1 hit paper
30 papers, 1.8k citations indexed

About

Xianting Li is a scholar working on Molecular Biology, Neurology and Epidemiology. According to data from OpenAlex, Xianting Li has authored 30 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Neurology and 8 papers in Epidemiology. Recurrent topics in Xianting Li's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Autophagy in Disease and Therapy (6 papers) and Cellular transport and secretion (3 papers). Xianting Li is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Autophagy in Disease and Therapy (6 papers) and Cellular transport and secretion (3 papers). Xianting Li collaborates with scholars based in United States, China and United Kingdom. Xianting Li's co-authors include Zhenyu Yue, Nina Pan, Shibu M. Poulose, Xin‐Yun Huang, C. Warren Olanow, Jyoti C. Patel, Charles Nicholson, Marat V. Avshalumov, Margaret E. Rice and Gregory A. Elder and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Xianting Li

27 papers receiving 1.8k citations

Hit Papers

Autophagy enables microglia to engage amyloid plaques and... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianting Li United States 17 721 704 496 323 265 30 1.8k
Shawn Hayley Canada 18 721 1.0× 664 0.9× 712 1.4× 290 0.9× 236 0.9× 30 1.8k
Fang Cai China 16 669 0.9× 545 0.8× 457 0.9× 501 1.6× 188 0.7× 51 1.8k
Roberto Di Maio United States 19 752 1.0× 796 1.1× 641 1.3× 365 1.1× 183 0.7× 35 1.8k
Mariaelena Repici Italy 19 287 0.4× 924 1.3× 629 1.3× 336 1.0× 170 0.6× 37 1.9k
Natalia V. Gounko Belgium 23 225 0.3× 1.1k 1.5× 495 1.0× 205 0.6× 324 1.2× 43 1.9k
Liliane Glauser Switzerland 20 667 0.9× 701 1.0× 432 0.9× 347 1.1× 341 1.3× 25 1.5k
M. Galbiati Italy 30 708 1.0× 1.1k 1.6× 658 1.3× 342 1.1× 508 1.9× 66 2.6k
Jerònia Lladó Spain 24 880 1.2× 1.1k 1.6× 849 1.7× 296 0.9× 92 0.3× 34 2.7k
Hyemyung Seo South Korea 35 572 0.8× 1.9k 2.7× 1.2k 2.4× 621 1.9× 363 1.4× 70 3.4k
Ikuko Mizuta Japan 26 891 1.2× 736 1.0× 762 1.5× 334 1.0× 166 0.6× 98 2.0k

Countries citing papers authored by Xianting Li

Since Specialization
Citations

This map shows the geographic impact of Xianting Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianting Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianting Li more than expected).

Fields of papers citing papers by Xianting Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianting Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianting Li. The network helps show where Xianting Li may publish in the future.

Co-authorship network of co-authors of Xianting Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xianting Li. A scholar is included among the top collaborators of Xianting Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianting Li. Xianting Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Yue, et al.. (2025). Prebiotic roles and anti-aging effects of xylo-oligosaccharide: Keystone responsive bacteria and their metabolic interactions. Food Research International. 215. 116673–116673. 2 indexed citations
2.
Li, Xianting, Xiaoting Zhou, Yuanxi Zhang, et al.. (2025). Targeting specific kinase substrates rescues increased colitis severity induced by the Crohn’s disease–linked LRRK2-N2081D variant. Journal of Clinical Investigation. 135(19).
3.
5.
Zhou, Xiaoting, Xianting Li, Henry Kim, et al.. (2024). Integrated proteomics reveals autophagy landscape and an autophagy receptor controlling PKA-RI complex homeostasis in neurons. Nature Communications. 15(1). 3113–3113. 12 indexed citations
6.
Li, Zhenchao, et al.. (2024). Unified Modeling and Control Methods for Ripple Power Decoupling Circuit Based on DC-Split Capacitor. IEEE Transactions on Power Electronics. 40(1). 665–678. 1 indexed citations
7.
Choi, Insup, Minghui Wang, Seungyeul Yoo, et al.. (2023). Autophagy enables microglia to engage amyloid plaques and prevents microglial senescence. Nature Cell Biology. 25(7). 963–974. 106 indexed citations breakdown →
8.
Li, Xianting, et al.. (2023). Long Non-Coding RNA BCAR4 Promotes Oxaliplatin Resistance in Colorectal Cancer by Modulating miR-484-3p/RAB5C Expression. Chemotherapy. 68(3). 119–130. 4 indexed citations
9.
10.
Schaffner, Adam, Xianting Li, Yacob Gómez-Llorente, et al.. (2019). Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection. Cell Research. 29(4). 313–329. 53 indexed citations
12.
Pan, Ping‐Yue, Xianting Li, Jing Wang, et al.. (2017). Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons. Journal of Neuroscience. 37(47). 11366–11376. 97 indexed citations
13.
Qin, Qi, Lianteng Zhi, Xianting Li, et al.. (2016). Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission. CNS Neuroscience & Therapeutics. 23(2). 162–173. 23 indexed citations
14.
Friedman, Allyson K., Jessica J. Walsh, Barbara Juarez, et al.. (2014). Enhancing Depression Mechanisms in Midbrain Dopamine Neurons Achieves Homeostatic Resilience. Science. 344(6181). 313–319. 358 indexed citations
15.
Mesias, Roxana, et al.. (2013). Short- and Long-Term Effects of LRRK2 on Axon and Dendrite Growth. PLoS ONE. 8(4). e61986–e61986. 38 indexed citations
16.
Li, Xianting, Qing Jun Wang, Nina Pan, et al.. (2011). Phosphorylation-Dependent 14-3-3 Binding to LRRK2 Is Impaired by Common Mutations of Familial Parkinson's Disease. PLoS ONE. 6(3). e17153–e17153. 136 indexed citations
17.
Li, Xianting, Jyoti C. Patel, Jing Wang, et al.. (2010). Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S. Journal of Neuroscience. 30(5). 1788–1797. 269 indexed citations
18.
Yu, Yanshun, et al.. (2009). An improved model and the thermodynamic calculation method for tailrace tunnel ventilating system in hydropower station. Energy Conversion and Management. 50(8). 2060–2066. 8 indexed citations
19.
Li, Xianting, et al.. (2007). Leucine‐rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson’s disease R1441C/G mutants. Journal of Neurochemistry. 103(1). 238–247. 194 indexed citations
20.
Lou, Yaxin, Wenling Han, Ying Wang, et al.. (2003). Molecular cloning and characterization of rat chemokine-like factor 1 and 2. Gene. 307. 125–132. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026